Impact of Anti-TNFα Therapy on Foot Ulcerations in a Patient with Ankylosing Spondylitis
Author Information
Author(s): Edgson Lucy, Field Robert, Westlake Sarah
Primary Institution: Bournemouth and Poole Community Health Services, Bournemouth, UK
Hypothesis
What are the consequences of anti-TNFα therapy on foot ulcerations in patients with Ankylosing Spondylitis?
Conclusion
The case highlights the complications arising from anti-TNFα therapy in patients with foot wounds, including infection and impaired healing.
Supporting Evidence
- The patient experienced foot ulceration and cellulitis after Infliximab administration.
- Management included multiple antibiotics and weekly podiatric care.
- Stopping Infliximab led to a flare of arthritis and complications in wound management.
- Active inflammation impaired wound healing.
Takeaway
A patient with a foot ulcer got worse after stopping their medication, showing that the medicine can help but also has risks.
Methodology
Case study involving a 50-year-old male with Ankylosing Spondylitis treated with Infliximab.
Potential Biases
Patient reluctance to report foot problems due to perceived benefits of the drug.
Limitations
The study is based on a single case, limiting generalizability.
Participant Demographics
50-year-old male with Ankylosing Spondylitis.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website